首頁 > 市場調查報告書 > 製藥

神經疾病

市場調查報告書

商品編碼

1766576

神經保護市場依產品類型、作用機制、應用、病患人口統計、性別、給藥途徑、銷售管道和地區分類

Neuroprotection Market, By Product Type, By Mechanism of Action, By Application, By Patient Demographics, By Gender, By Route of Administration, By Distribution Channel, By Geography

出版日期: 2025年06月02日 | 出版商:

Coherent Market Insights | 英文 135 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

神經保護市場規模預計在 2025 年為 351 億美元，預計到 2032 年將達到 578.5 億美元，2025 年至 2032 年的年複合成長率（CAGR）為 7.4%。

報告範圍		報告詳細資訊
基準年	2024	2025年的市場規模	351億美元
效能數據	從2020年到2024年	預測期	2025年至2032年
預測期：2025-2032年複合年成長率：	7.40%	2032年價值預測	578.5億美元

全球神經保護市場已成為醫療保健行業的關鍵領域，專注於開發和應用治療策略，以保護神經系統免受各種神經疾病和損傷的損害。神經保護涵蓋一系列旨在透過預防或減緩神經元細胞喪失的進展來保護認知功能和改善患者預後的方法。由於阿茲海默症、帕金森氏症、創傷性腦損傷和中風等神經系統疾病的盛行率不斷上升，該市場吸引了研究人員、製藥公司和醫療保健提供者的極大關注。隨著人口老化和這些疾病負擔的增加，對有效的神經保護干預措施的需求激增，推動了該領域的創新和投資。

市場動態：

全球神經保護市場的成長受到多種關鍵因素的推動，例如神經病變盛行率的上升、人口老化加劇以及人們對早期療育在預防神經病變方面重要性的認知不斷提高。阿茲海默症和帕金森氏症等神經退化性疾病的盛行率不斷上升，對神經保護療法的需求龐大。此外，事故和體育相關活動導致的創傷性腦損傷的發生率也促進了市場的成長。然而，市場面臨某些限制因素，例如高昂的藥物開發成本以及跨越血腦障壁輸送治療藥物的挑戰。

此外，缺乏有效的診斷工具來早期發現神經系統疾病，阻礙了及時介入和治療。儘管面臨這些挑戰，市場仍蘊藏著巨大的成長和創新機會。對個人化醫療和標靶治療的日益關注為神經保護提供了充滿希望的途徑。基因組學、蛋白質組學和生物標記發現領域的發展為識別新型藥物標靶和開發精準治療創造了新的可能性。此外，學術界、產業界和政府機構之間日益深化的合作正在推動研發工作，並加速將臨床前試驗中獲得的見解轉化為臨床應用。

本研究的主要特點

本報告對全球神經保護市場進行了詳細分析，並給出了預測期（2025-2032 年）的市場規模（十億美元）和年複合成長率（CAGR%），假設 2024 年為基準年。
它還強調了各個領域的潛在商機，並說明了該市場的有吸引力的投資提案矩陣。
它還提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域前景和主要企業採用的競爭策略的重要見解。
全球神經保護市場的主要企業是根據公司亮點、產品系列、關鍵亮點、財務績效和策略等參數進行的分析。
本報告的見解將使負責人和企業經營團隊能夠就未來的產品發布、新興趨勢、市場擴張和行銷策略做出明智的決策。
全球神經保護市場報告迎合了該行業的各個相關人員，包括投資者、供應商、產品製造商、經銷商、新進業者和金融分析師。
相關人員將透過用於分析全球神經保護市場的各種策略矩陣來做出決策。

Report Coverage	Report Details
Base Year:	2024	Market Size in 2025:	USD 35.10 Bn
Historical Data for:	2020 To 2024	Forecast Period:	2025 To 2032
Forecast Period 2025 to 2032 CAGR:	7.40%	2032 Value Projection:	USD 57.85 Bn

The global neuroprotection market has emerged as a vital sector within the healthcare industry, focusing on the development and application of therapeutic strategies to safeguard the nervous system from damage caused by various neurological disorders and injuries. Neuroprotection encompasses a wide range of approaches aimed at preventing or mitigating the progression of neuronal loss, thereby preserving cognitive function and improving patient outcomes. This market has garnered significant attention from researchers, pharmaceutical companies, and healthcare providers due to the increasing prevalence of neurological conditions such as Alzheimer's disease, Parkinson's disease, traumatic brain injury, and stroke. With the growing aging population and the rising burden of these disorders, the demand for effective neuroprotective interventions has surged, driving innovation and investment in this field.

Market Dynamics:

The global neuroprotection market growth is driven by several key factors, including the increasing prevalence of neurological disorders, growing aging population, and rising awareness about the importance of early intervention in preventing neurological damage. The prevalence of neurodegenerative diseases such as Alzheimer's and Parkinson's has been on the rise, creating a significant demand for neuroprotective therapies. Additionally, the incidence of traumatic brain injuries due to accidents and sports-related activities has also contributed to the market growth. However, the market faces certain restraints, such as the high cost of drug development and the challenges associated with delivering therapeutics across the blood-brain barrier.

Moreover, the lack of effective diagnostic tools for early detection of neurological disorders hinders timely intervention and treatment. Despite these challenges, the market presents substantial opportunities for growth and innovation. The increasing focus on personalized medicine and the development of targeted therapies offer promising avenues for neuroprotection. Advancements in genomics, proteomics, and biomarker discovery have opened up new possibilities for identifying novel drug targets and developing precision therapies. Furthermore, the growing collaboration between academia, industry, and government organizations has fostered research and development efforts, accelerating the translation of preclinical findings into clinical applications.

Key features of the study:

This report provides an in-depth analysis of the global neuroprotection market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global neuroprotection market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Biogen Inc., Amgen Inc., Novartis AG, Eli Lilly and Company, Roche Holding AG, Pfizer Inc., Sanofi S.A., Merck & Co., Inc., AstraZeneca PLC, Teva Pharmaceutical Industries Ltd., Johnson & Johnson, AbbVie Inc., GSK (GlaxoSmithKline), Takeda Pharmaceutical Company Limited, and UCB S.A.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global neuroprotection market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global neuroprotection market

Market Segmentation

Product Type Insights (Revenue, USD Bn, 2020 - 2032)
- Pharmaceuticals
- Biologics
- Nutraceuticals
- Others
Mechanism Of Action Insights (Revenue, USD Bn, 2020 - 2032)
- Antioxidants
- Anti-inflammatory Drugs
- Neurotransmitter Modulators
- Calcium Channel Blockers
- NMDA Receptor Antagonists
- Others
Application Insights (Revenue, USD Bn, 2020 - 2032)
- Alzheimer's Disease
- Parkinson's Disease
- Multiple Sclerosis
- Amyotrophic Lateral Sclerosis (ALS)
- Huntington's Disease
- Traumatic Brain Injury (TBI)
- Ischemic Stroke
- Epilepsy
- Retinal Degeneration
- Glaucoma
- Spinal Cord Injuries
- Others
Patient Demographics Insights (Revenue, USD Bn, 2020 - 2032)
- Pediatric Patients
- Adult Patients
- Geriatric Patients
Gender Insights (Revenue, USD Bn, 2020 - 2032)
- Male
- Female
Route Of Administration Insights (Revenue, USD Bn, 2020 - 2032)
- Oral
- Injectable
- Intranasal
- Transdermal
- Sublingual
Distribution Channel Insights (Revenue, USD Bn, 2020 - 2032)
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
Regional Insights (Revenue, USD Bn, 2020 - 2032)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
Key Players Insights
- Biogen Inc.
- Amgen Inc.
- Novartis AG
- Eli Lilly and Company
- Roche Holding AG
- Pfizer Inc.
- Sanofi S.A.
- Merck & Co., Inc.
- AstraZeneca PLC
- Teva Pharmaceutical Industries Ltd.
- Johnson & Johnson
- AbbVie Inc.
- GSK (GlaxoSmithKline)
- Takeda Pharmaceutical Company Limited
- UCB S.A.

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Global Neuroprotection Market, By Product Type
- Global Neuroprotection Market, By Mechanism of Action
- Global Neuroprotection Market, By Application
- Global Neuroprotection Market, By Patient Demographics
- Global Neuroprotection Market, By Gender
- Global Neuroprotection Market, By Route of Administration
- Global Neuroprotection Market, By Distribution Channel
- Global Neuroprotection Market, By Region

3. Market Dynamics, Regulations, And Trends Analysis

Market Dynamics
Driver
Restraint
Opportunity
Impact Analysis
Key Developments
Regulatory Scenario
Product Launches/Approvals
PEST Analysis
PORTER's Analysis
Merger and Acquisition Scenario
Industry Trends

4. Global Neuroprotection Market, By Product Type, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Pharmaceuticals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Biologics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Nutraceuticals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

5. Global Neuroprotection Market, By Mechanism of Action, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Antioxidants
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Anti-inflammatory Drugs
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Neurotransmitter Modulators
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Calcium Channel Blockers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
NMDA Receptor Antagonists
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

6. Global Neuroprotection Market, By Application, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Alzheimer's Disease
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Parkinson's Disease
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Multiple Sclerosis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Amyotrophic Lateral Sclerosis (ALS)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Huntington's Disease
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Traumatic Brain Injury (TBI)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Ischemic Stroke
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Epilepsy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Retinal Degeneration
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Glaucoma
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Spinal Cord Injuries
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

7. Global Neuroprotection Market, By Patient Demographics, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Pediatric Patients
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Adult Patients
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Geriatric Patients
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

8. Global Neuroprotection Market, By Gender, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Male
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Female
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

9. Global Neuroprotection Market, By Route of Administration, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Oral
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Injectable
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Intranasal
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Transdermal
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Sublingual
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

10. Global Neuroprotection Market, By Distribution Channel, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Hospital Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Online Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

11. Global Neuroprotection Market, By Region, 2020 - 2032, Value (USD Bn)

Introduction
- Market Share (%) Analysis, 2025, 2028 & 2032, Value (USD Bn)
- Market Y-o-Y Growth Analysis (%), 2020 - 2032, Value (USD Bn)
- Regional Trends
North America
- Introduction
- Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Mechanism of Action, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Patient Demographics, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Gender, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Mechanism of Action, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Patient Demographics, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Gender, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
  - Brazil
  - Argentina
  - Mexico
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Mechanism of Action, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Patient Demographics, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Gender, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
  - Germany
  - U.K.
  - Spain
  - France
  - Italy
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Mechanism of Action, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Patient Demographics, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Gender, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
  - China
  - India
  - Japan
  - Australia
  - South Korea
  - ASEAN
  - Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Mechanism of Action, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Patient Demographics, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Gender, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
  - GCC Countries
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Mechanism of Action, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Patient Demographics, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Gender, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country/Region, 2020 - 2032, Value (USD Bn)
  - South Africa
  - North Africa
  - Central Africa

12. Competitive Landscape

Biogen Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Amgen Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Novartis AG
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Eli Lilly and Company
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Roche Holding AG
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Pfizer Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Sanofi S.A.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Merck & Co., Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
AstraZeneca PLC
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Teva Pharmaceutical Industries Ltd.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Johnson & Johnson
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
AbbVie Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
GSK (GlaxoSmithKline)
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Takeda Pharmaceutical Company Limited
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
UCB S.A.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies

13. Analyst Recommendations

Wheel of Fortune
Analyst View
Coherent Opportunity Map

14. References and Research Methodology

References
Research Methodology
About us

02-2729-4219

+886-2-2729-4219

License/價格

相關商品

神經保護市場，按產品類型、按疾病適應症、按作用機制、按最終用戶、按國家和地區分類 - 2025 年至 2032 年全球行業分析、市場規模、市場佔有率和預測

神經保護市場：按產品、治療、給藥途徑、應用和最終用戶 - 全球預測 2025-2030

神經保護市場 - 副產品（抗氧化劑、細胞凋亡抑制劑、抗發炎藥物、谷氨酸拮抗劑、金屬離子螯合劑、抗憂鬱藥物）、給藥途徑、應用、配銷通路- 全球預測 2024 - 2032

神經保護市場 - 2023-2031 年全球產業分析、規模、佔有率、成長、趨勢和預測

2030 年神經免疫藥物市場預測：按產品類型、適應症和地區分類的全球分析

FAQ

神經保護市場依產品類型、作用機制、應用、病患人口統計、性別、給藥途徑、銷售管道和地區分類